IP Library Granted Patent US 8,367,808
Granted Patent B2
US 8,367,808 · App. 13/182,585 · Granted Feb 5, 2013

Methods, devices, kits and compositions for detecting whipworm

Inventors: David Allen Elsemore (South Portland, ME); Laurie A. Flynn (Raymond, ME); Michael Crawford (St. Louis, MO)
Assignees: IDEXX Laboratories, Inc.; Divergence, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,367,808
App. No.
13/182,585
Granted
Feb 5, 2013
Kind
B2
Abstract

Methods, devices, kits and compositions for detecting the presence or absence of whipworm in a fecal sample are disclosed herein. The methods, devices, kits and compositions of the present invention may be used to confirm the presence or absence of whipworm in a fecal sample from a mammal that may also be infected with one or more of hookworm, roundworm, and heartworm. Confirmation of the presence or absence of whipworm in the mammal may be made, for example, for the purpose of selecting an optimal course of treating the mammal and/or for the purpose of determining whether the mammal has been rid of the infection after treatment has been initiated.

Claims (10)

1. An isolated antibody wherein the antibody specifically binds to the polypeptide consisting of the amino acid sequence of SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, or SEQ ID NO:9.

2. The isolated antibody of claim 1 , wherein the antibody is obtained by immunization with a polypeptide consisting of the amino acid sequence of SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, or SEQ ID NO:9.

3. The isolated antibody of claim 1 , wherein the antibody is detectably labeled.

4. The isolated antibody of claim 1 , wherein the antibody specifically binds to whipworm antigen in a fecal sample obtained from a whipworm-infected mammal.

5. The isolated antibody of claim 4 , wherein the whipworm infected mammal is further infected with one or more of hookworm, roundworm and heartworm and the antibody does not bind to any antigen from the one or more of hookworm, roundworm, or heartworm that may be present in the fecal sample.

6. The isolated antibody of claim 1 , wherein the antibody is immobilized on a solid support.

7. The isolated antibody of claim 4 , wherein the whipworm is Trichuris vulpis.

8. The isolated antibody of claim 5 , wherein the hookworm is Ancylostoma caninum , the roundworm is Toxocara canis , and/or the heartworm is Dirofilaria immitis.

9. The isolated antibody of claim 1 , wherein the antibody is a single chain antibody, or an antigen binding fragment of an antibody.

10. The isolated antibody of claim 1 , wherein the antibody is a polyclonal or monoclonal antibody.

Assignments (3)
MERGER AND CHANGE OF NAME Recorded Dec 5, 2018
From: DIVERGENCE, INC.; MONSANTO COMPANY
To: MONSANTO COMPANY
Reel/Frame 047680/0449 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2011
From: ELSEMORE, DAVID ALLEN; FLYNN, LAURIE A.
To: IDEXX LABORATORIES, INC.
Reel/Frame 026601/0389 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2011
From: CRAWFORD, MICHAEL
To: DIVERGENCE, INC.
Reel/Frame 026601/0396 →
Continuity (3)
Division 12467794 · May 18, 2009
Provisional Application 61128077 · May 19, 2008
Related Publication 20120208983A1 · Aug 16, 2012